RNA-Seq analysis of Candida glabrata wild-type and... (ID 836887) - BioProject

Display Settings:

Format

Summary
BioProject ID list
Accessions List

Send to:

Choose Destination

File
Clipboard
Collections
My Bibliography

Accession: PRJNA836887 ID: 836887

RNA-Seq analysis of Candida glabrata wild-type and Cgset4Δ mutant in the presence and absence of the cell wall targeting echinocandin antifungal drug, caspofungin.

See Genome Information for Nakaseomyces glabratus

Navigate Across

113 additional projects are related by organism.

To determine the effect of caspofungin (CSP) treatment and/or loss of the SET domain-containing CgSet4 protein on the transcriptional response of log-phase C. More...

Accession	PRJNA836887; GEO: GSE202654
Data Type	Transcriptome or Gene expression
Scope	Multiisolate
Organism	Nakaseomyces glabratus[Taxonomy ID: 5478] Eukaryota; Fungi; Dikarya; Ascomycota; Saccharomycotina; Saccharomycetes; Saccharomycetales; Saccharomycetaceae; Nakaseomyces; Nakaseomyces glabratus
Publications	Bhakt P et al., "The SET-domain protein CgSet4 negatively regulates antifungal drug resistance via the ergosterol biosynthesis transcriptional regulator CgUpc2a.", J Biol Chem, 2022 Oct;298(10):102485
Submission	Registration date: 10-May-2022 Laboratory of Fungal Pathogenesis, Centre for DNA Fingerprinting and Diagnostics
Relevance	Unknown

Project Data:

Resource Name	Number of Links
Sequence data
SRA Experiments	8
Publications
PubMed	1
PMC	1
Other datasets
BioSample	8
GEO DataSets	1

GEO Data Details

Parameter	Value
Data volume, Supplementary Mbytes	2

SRA Data Details

Parameter	Value
Data volume, Gbases	41
Data volume, Mbytes	18214

BioProject

Result Filters

Display Settings:

Send to:

RNA-Seq analysis of Candida glabrata wild-type and Cgset4Δ mutant in the presence and absence of the cell wall targeting echinocandin antifungal drug, caspofungin.

Supplemental Content

Recent activity